Cite

HARVARD Citation

    Langrand-Escure, J. et al. (2016). Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma. Anti-cancer drugs. 27 (5), p. . [Online]. 
  
Back to record